Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2020-09-16
2023-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Investigate the Effect of Protein in Infant Formula on Insulin Response in Adults
NCT04332510
Is Milk Associated with Glycemia in the NICU
NCT05256927
Efficacy of a New Infant Formula Composition on Gut Health in Infants
NCT07242508
Effect of Formula on Infant Behavior
NCT02746016
Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers
NCT05049655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard formula
Participants receiving intact protein lactose-based formula, exclusively for at least 3 months.
No interventions assigned to this group
Sensitive
Participants receiving intact protein glucose/sucrose- based formula, exclusively for at least 3 months.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton birth
* Healthy Infants
* Infant between 3-6 months at the time of visit and exclusively fed one of the formulas for a minimum of 3 months
Exclusion Criteria
* Infant birth weight \<2500g
* Infants exhibiting growth faltering (loss of more than 25 percentile points) between 1 month to the time of study visit for either weight or length.
* Infant medical or genetic indications that would impact normal feeding behavior, insulin signaling or growth patterns.
* Infant consumption of more than two servings of complementary foods per day before the study visit.
5 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bridget Young
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Center of the University of Rochester Medical Center
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00004724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.